RBC Capital Markets initiated coverage on Alpine Immune Sciences Inc ALPN, noting that the autoimmune disease market (over $165 billion) is meaningful for the…
RBC Capital Markets initiated coverage on Alpine Immune Sciences Inc (NASDAQ: ALPN), noting that the autoimmune disease market (over $165 billion) is meaningful for the company's lead candidate - povetacicept
MORF Stock Collapses 52% Over Two Days As Takeda Rivalry Slams Ulcerative Colitis Drug investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
MORF Stock Collapses 52% Over Two Days As Takeda Rivalry Slams Ulcerative Colitis Drug investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.